companydata.dkcompanydata.dk

PHARMCO I ApS: Financial statements 2023

CVR: 25204042

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

PHARMCO I ApS (CVR 25204042) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -112,000 and a net result of DKK 32,297,000 compared with DKK 17,542,000 the year before. Equity in the 2023 report amounted to DKK 364,555,000. The solvency ratio was 99.2%. The company had 416 employees in the financial year.

Revenue
DKK 0
Gross Profit
DKK -112,000
Profit/Loss
DKK 32,297,000
Equity
DKK 364,555,000
Total Assets
DKK 367,442,000
Employees
416

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20230-112 t.32.3 mio.364.6 mio.416
20220-72 t.17.5 mio.332.8 mio.425
20210-69 t.43.2 mio.316.3 mio.420
20200-82 t.36.1 mio.272.5 mio.394
20190-66 t.31.6 mio.237.2 mio.375

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

PHARMCO I ApS: The 2022 annual report is outJun 12, 2023

PHARMCO I ApS has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK 17,542,000.

About PHARMCO I ApS

PHARMCO I ApS is a Danish company of the type Anpartsselskab based in Vojens, founded in 2000. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Eli Wallin. The company is owned by Eli Wallin. According to the 2025 annual report, the company had an average of 473 employees. In 2025, the company reported a gross profit of DKK -105,000 and a net result of DKK 92,326,000 compared with DKK 44,804,000 the year before. Equity in the 2025 report amounted to DKK 469,411,000.

Source: annual report 2025, Danish Business Authority